Seastar Medical Holding Corp (ICU)

$4.28

-0.01

(-0.23%)

Market is closed - opens 7 PM, 07 Oct 2024

Performance

  • $4.10
    $4.38
    $4.28
    downward going graph

    4.21%

    Downside

    Day's Volatility :6.39%

    Upside

    2.28%

    downward going graph
  • $3.25
    $42.92
    $4.28
    downward going graph

    24.07%

    Downside

    52 Weeks Volatility :92.43%

    Upside

    90.03%

    downward going graph

Returns

PeriodSeastar Medical Holding CorpIndex (Russel 2000)
3 Months
-62.82%
0.0%
6 Months
-74.03%
0.0%
1 Year
-67.99%
0.0%
3 Years
-98.42%
-20.1%

Highlights

Market Capitalization
18.0M
Book Value
- $2.14
Earnings Per Share (EPS)
-18.55
Wall Street Target Price
18.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-308.09%
Return On Equity TTM
0.0%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
Diluted Eps TTM
-18.55
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-7.99
EPS Estimate Next Year
-2.57
EPS Estimate Current Quarter
-1.41
EPS Estimate Next Quarter
-1.25

Analyst Recommendation

Buy
    80%Buy
    20%Hold
    0
    0%Sell
Based on 5 Wall street analysts offering stock ratings for Seastar Medical Holding Corp(by analysts ranked 0 to 5 stars)
Based on 5 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
4
4
4
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 320.56%

Current $4.28
Target $18.00

Technicals Summary

Sell

Neutral

Buy

Seastar Medical Holding Corp is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Seastar Medical Holding Corp
Seastar Medical Holding Corp
-11.36%
-74.03%
-67.99%
-98.42%
-98.42%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-10.33%
8.11%
21.28%
85.63%
257.49%
Novo Nordisk A/s
Novo Nordisk A/s
-12.25%
-9.71%
24.92%
138.38%
343.21%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
9.22%
72.73%
52.35%
34.04%
250.13%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
-3.09%
12.2%
25.77%
150.7%
163.62%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Seastar Medical Holding Corp
Seastar Medical Holding Corp
NA
NA
NA
-7.99
0.0
-3.08
NA
-2.14
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
27.55
27.55
1.42
45.05
0.17
0.08
NA
261.41
Novo Nordisk A/s
Novo Nordisk A/s
38.7
38.7
1.75
3.41
0.89
0.23
0.01
25.24
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-2.49
-15.01
0.02
NA
-0.02
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
0.55
0.32
-0.03
0.13
NA
57.26
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Seastar Medical Holding Corp
Seastar Medical Holding Corp
Buy
$18.0M
-98.42%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$114.7B
257.49%
27.55
32.04%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$518.0B
343.21%
38.7
34.84%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$34.9B
250.13%
NA
-3.11%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$119.3B
163.62%
32.84
-4.74%

Insights on Seastar Medical Holding Corp

  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 52.3% return, outperforming this stock by 120.3%

Institutional Holdings

  • Bank of America Corp

    0.80%
  • Geode Capital Management, LLC

    0.74%
  • UBS Group AG

    0.69%
  • Vanguard Group Inc

    0.66%
  • Morgan Stanley - Brokerage Accounts

    0.28%
  • BlackRock Inc

    0.22%

Company Information

Organization
Seastar Medical Holding Corp
Employees
12
CEO
Mr. Eric Schlorff
Industry
Miscellaneous

FAQs